ArticleBritish journal of pharmacology2013

A novel androgen signalling pathway uses dihydrotestosterone, but not testosterone, to activate the EGF receptor signalling cascade in prostate stromal cells.

V L Oliver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.